Patients with amyloidosis have been immeasurably aided through advances derived from laboratory and translational research programs coordinated by clinical investigators at BMC and laboratory investigators at Boston University School of Medicine (BUSM). The Center at BUSM has been in existence since 1960, and has been responsible for many advances in the field, including some of the first randomized treatment trials, stem cell transplant trials, trials with novel agents and small molecules, and protocols for liver and heart transplantation for selected patients. To learn about our research, please visit the Amyloidosis Center website at BUSM.